Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM7XTHD)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
SRC 909; BRN 0622820; 1897-90-1; 2-(2-(3-Pyridyl)-ethenyl)-3-(o-tolyl)-4(3H)-quinazolinone; 2-(beta-Pyridyl-(3'')-aethenyl)-3-(o-tolyl)chinazolinone-(4) [German]; 4(3H)-Quinazolinone, 2-(2-(3-pyridyl)ethenyl)-3-(o-tolyl)-; 3-(2-methylphenyl)-2-(2-(3-pyridinyl)ethenyl)-4(3H)-quinazolinone; 4(3H)-Quinazolinone, 3-(2-methylphenyl)-2-(2-(3-pyridinyl)ethenyl)-; SRC-909; AC1NWBSK; AC1Q6E7H; MolPort-001-954-696; MolPort-019-773-808; 2-(beta-Pyridyl-(3'')-aethenyl)-3-(o-tolyl)chinazolinone-(4); ZINC4018972; STK721935
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
|||||||||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||